Results revive wilting shares in biotechs
Tuesday 25 March 1997
Shield soared 40p to 690p after it said British tests on its activated factor twelve (AFT) "point towards" it becoming a significant tool for the prediction of heart disease in the general population.
Separately, PPL saw its shares rise 20p to 447.5p on news that it had extended its transgenic drug creation technology to rabbits. The gain makes up some of the ground lost since the price jumped and then collapsed a month ago after the announcement that it held an exclusive licence to Dolly the sheep, the world's first cloned animal.
Dundee-based Shield yesterday played down the importance of the collapse of US trials on AFT, the announcement of which late on Friday prompted a collapse in the share price to 667.5p after having rocketed to a peak of 919p. A spokeswoman for the company described the study of 700 patients in a 10-year-old US government-sponsored programme as "in a sense a bonus study, because the main ones are in the UK".
Yesterday the company was concentrating on the UK tests. Shield said they showed that increased AFT levels in the blood correlated with an increased risk of disease. At the same time, there were over 30 per cent higher levels of AFT in patients with coronary heart disease than healthy people, compared with 7 per cent more cholesterol, an existing test marker.
Separately, PPL announced it had successfully produced a so-called amidated peptide in the milk of genetically modified rabbits. The production of calcitonin, the first time a peptide of this class has been produced, was being claimed as offering the potential for a greater number of pharmaceutical products to be generated from transgenic technology. Calcitonin is used in the treatment of ailments such as brittle bone disease.
- 1 Snoop Dogg and Jared Leto buy a stake in Reddit as A-list invests $50m
- 2 Prince held a Facebook Q&A and this is the only question he answered
- 3 Car tax disc changes: Two days to go - and they affect you much more than just not displaying a piece of paper
- 4 Now we know whose fault it is if you end up being murdered in Thailand
- 5 35,000 walrus gather ashore on north-west Alaska beach 'for a rest'
Exclusive: 'Putin's Russia has been my biggest regret,' says Nato's outgoing Secretary General
The Osborne Ultimatum: Chancellor’s benefits freeze bombshell will affect ten million households
There’s no excuse for Dave Lee Travis’s behaviour, but we need to keep a sense of proportion
Should gay sex be illegal? 16% of Britons think so
Mark Reckless becomes second Tory MP to defect to Ukip in a month
Benefits 'smart cards' plan revealed by Iain Duncan Smith to stop claimants spending welfare money on alcohol
- < Previous
- Next >
iJobs Money & Business
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
NEGOTIABLE: Austen Lloyd: TRUST ACCOUNTANT - KENTIf you are a Chartered Accou...
£18000 - £20000 per annum + OTE £30000: SThree: SThree are a global FTSE 250 b...
Highly Competitive Salary: Austen Lloyd: CITY - Law Costs Draftsperson - NICHE...